KETOCONAZOLE cream

Land: Vereinigte Staaten

Sprache: Englisch

Quelle: NLM (National Library of Medicine)

Kaufe es jetzt

Herunterladen Fachinformation (SPC)
15-01-2018

Wirkstoff:

Ketoconazole (UNII: R9400W927I) (KETOCONAZOLE - UNII:R9400W927I)

Verfügbar ab:

REMEDYREPACK INC.

INN (Internationale Bezeichnung):

Ketoconazole

Zusammensetzung:

Ketoconazole 20 mg in 1 g

Verschreibungstyp:

PRESCRIPTION DRUG

Berechtigungsstatus:

Abbreviated New Drug Application

Fachinformation

                                KETOCONAZOLE - KETOCONAZOLE CREAM
REMEDYREPACK INC.
----------
KETOCONAZOLE CREAM, 2%
SPL UNCLASSIFIED
RX ONLY
DESCRIPTION
Ketoconazole cream, 2% contains the broad-spectrum synthetic
antifungal agent, ketoconazole 2%,
formulated in an aqueous cream vehicle consisting of butylated
hydroxyanisole (BHA), cetyl alcohol,
isopropyl myristate, polysorbate 60, polysorbate 80, propylene glycol,
purified water, sorbitan
monostearate and stearyl alcohol.
Ketoconazole is
_cis_-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1_H_-imidazol-1-ylmethyl)-1,3-dioxolan-
4-yl]methoxy]phenyl] piperazine and has the following structural
formula:
Molecular Formula: C
H Cl
N O
Molecular Weight: 531.43
CLINICAL PHARMACOLOGY
When ketoconazole cream, 2% was applied dermally to intact or abraded
skin of beagle dogs for 28
consecutive days at a dose of 80 mg, there were no detectable plasma
levels using an assay method
having a lower detection limit of 2 ng/mL.
After a single topical application to the chest, back and arms of
normal volunteers, systemic absorption
of ketoconazole was not detected at the 5 ng/mL level in blood over a
72-hour period.
Two dermal irritancy studies, a human sensitization test, a
phototoxicity study and a photoallergy study
conducted in 38 male and 62 female volunteers showed no contact
sensitization of the delayed
hypersensitivity type, no irritation, no phototoxicity and no
photoallergenic potential due to
ketoconazole cream, 2%.
Ketoconazole is a broad spectrum synthetic antifungal agent which
inhibits the _in vitro_ growth of the
following common dermatophytes and yeasts by altering the permeability
of the cell membrane:
dermatophytes: _Trichophyton rubrum, T. mentagrophytes, T. tonsurans,
Microsporum canis, M. audouini,_
26
28
2
4
4
_M. gypseum_ and _Epidermophyton floccosum; yeasts: Candida albicans,
Malassezia ovale (Pityrosporum_
_ovale)_ and _C. tropicalis;_ and the organism responsible for tinea
versicolor, _Malassezia furfur_
_(Pityrosporum orbiculare)._ Only those organisms listed in the
INDICATIONS AND USA
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Suchen Sie nach Benachrichtigungen zu diesem Produkt

Dokumentverlauf anzeigen